US Stock MarketDetailed Quotes
INMB INmune Bio
- 4.870
- +0.110+2.31%
Close Nov 22 16:00 ET
- 4.820
- -0.050-1.03%
Post 16:35 ET
108.35MMarket Cap-2233P/E (TTM)
4.980High4.700Low129.89KVolume4.760Open4.760Pre Close633.72KTurnover0.90%Turnover RatioLossP/E (Static)22.25MShares14.74052wk High2.80P/B70.06MFloat Cap4.45052wk Low--Dividend TTM14.39MShs Float30.370Historical High--Div YieldTTM5.88%Amplitude2.200Historical Low4.879Avg Price1Lot Size
About INmune Bio Company
INmune Bio, Inc. Is a clinical stage biotechnology company, which engages in developing new immunotherapies that reprograms the immune system to fight cancer and Alzheimer’s disease. Its products include pipeline, INKMUNE-Cancer, INB03-Cancer, XPRO1595-Alzheimer and TRD, and LIVNate. The company was founded by Mark Lowdell in September 2015 and is headquartered in Boca Raton, FL.
Company Profile
SymbolINMB
Company NameINmune Bio
Listing DateFeb 4, 2019
Issue Price8.00
Founded2015
CEODr. Raymond J. Tesi, M.D.
MarketNASDAQ
Employees17
Fiscal Year Ends12-31
Address225 NE Mizner Boulevard,Suite 640
CityBoca Raton
ProvinceFlorida
CountryUnited States of America
Zip Code33432
Phone1-858-964-3720
Websitehttp://www.inmunebio.com
Company Executives
- Name
- Position
- Salary
- Dr. Raymond J. Tesi, M.D.
- Director, President and Chief Executive Officer
- 1.69M
- David J. Moss
- Principal Accounting Officer, Chief Financial Officer, Treasurer and Secretary
- 1.59M
- Dr. Mark Lowdell, PhD
- Chief Scientific Officer
- 150.24K
- Scott Juda, J.D.
- Independent Director
- 301.26K
- J. Kelly Ganjei
- Independent Director
- 301.26K
- Marcia Allen
- Independent Director
- 301.26K
- Timothy (Tim) Schroeder
- Independent Director
- 301.26K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data